Fig. 3From: Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysisKaplan–Meier analysis of time (months) to clinical relapse after discontinuation of infliximab. Panel A demonstrates the time to clinical relapse of index organ in individual patients who initially responded to infliximab. Panel B describes the time to clinical worsening in index organs for which infliximab was prescribedBack to article page